Search by:
Alphabetically by Last Name:
|
Quick Search |
|
|
|
Advanced Search |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher
G.
Campbell
Partner
|
Christopher G. Campbell, a partner in DLA Piper's global Litigation practice, focuses in the areas of mass tort, product liability and commercial litigation.
Mr. Campbell has experience in all phases of state and federal litigation, including discovery, depositions, motion practice, Daubert hearings, jury trials, arbitrations and appeals. He has represented many of DLA Piper's top clients, among them leading pharmaceutical, automotive and insurance companies. In addition, Mr. Campbell acts as US litigation counsel for international clients and regularly consults in the areas of risk management, employment law, intellectual property, contract litigation and other commercial areas.
Mr. Campbell earned his J.D. at Harvard Law School in 2000, where he was an executive editor of the Harvard Negotiation Law Review and a line editor of the International Law Journal and the Civil Rights-Civil Liberties Law Review. He also served as treasurer of the Harvard Law School Civil Liberties Union.
In 1997, Mr. Campbell graduated summa cum laude from Austin Peay State University (Clarksville, Tennessee), where he earned B.S. degrees in philosophy and English. In November 2002, Mr. Campbell was named the Austin Peay Outstanding Young Alumnus of the Year.
Recent Significant Representations
-
Drafted briefs on behalf of a global pharmaceutical manufacturer resulting in favorable Daubert decision excluding general causation opinions in numerous cases pending in federal multi-district litigation and New York state court
-
Successfully defended a global automobile manufacturer in a jury trial in New York State Court, which resulted in a directed verdict
-
Successfully defended a global pharmaceutical manufacturer in a US$25 million product liability action in California state court
-
Counsel for a leading pharmaceutical manufacturer in nationwide product liability matters involving popular anti-inflammatory medications
-
Successfully defended a global automobile manufacturer in a product liability action in the US District Court for the Western District of New York
-
Successfully defended a leading heavy equipment manufacturer in Daubert hearings and a jury trial in the US District Court for the Northern District of New York
-
Successfully defended a leading domestic automotive manufacturer in a US$30 million product liability action in the US District Court for the Eastern District of New York and in a US$10 million product liability action in New York state court
Recent Significant Decisions
-
Viramontes v. Pfizer, Inc., 2008 WL 2477443,*1 (Cal. Ct. App. June 20, 2008), affirming summary judgment in pharmaceutical product liability claim based on inadequacy of plaintiff's expert evidence
-
In re: Bextra and Celebrex Marketing Sales Practices and Prod. Liab. Litig., 524 F.Supp. 2d 1166, 2007 WL 4170276, *1 (N.D. Cal. Nov. 19, 2007), excluding as unreliable any expert opinions that pain medication causes heart attacks and strokes at most commonly prescribed dose
-
Polidoro v. Chubb Corp., 386 F. Supp. 2d 334 (S.D.N.Y. 2005), granting motion to dismiss a plaintiff’s claims in a bad faith insurance claim
-
Zaremba v. Gen. Motors Corp., 360 F.3d 355 (2d Cir. 2004), affirming summary judgment and excluding expert testimony under Daubert in a catastrophic, multi-plaintiff rollover crash
-
N.Y. Mut. Cent. Mut. Fire Ins. Co. v. Toyota Motor Sales, U.S.A., Inc., 2004 WL 2643172, *1 (W.D.N.Y. Nov. 18, 2004), granting summary judgment in an automobile fire case based on the inadequacy of the plaintiff's expert evidence to establish product defect
-
Utica Mut. Ins. Co. v. Computer Sciences Corp., 2004 WL 180252, *1 (N.D.N.Y. Jan. 23, 2004), granting motion to dismiss in multi-million dollar breach-of-contract action
-
Zaremba v. Gen. Motors Corp., 2003 WL 22331287, *1 (E.D.N.Y. April 25, 2003), granting summary judgment based on inadequacy of plaintiffs’ expert evidence under Daubert
-
Leibel v. Flynn Hill Elevator Co., 25 A.D.3d 768, 809 N.Y.S.2d 519 (2d Dep’t 2005), affirming trial court decision permitting amending third-party complaint in $20 million personal injury case
-
Figueroa v. Gallager, 20 A.D.3d 385, 798 N.Y.S.2d 143 (2d Dep't 2005), reversing trial court and granting summary judgment in favor of General Motors based on inadequacy of plaintiff’s expert testimony
Admissions
Publications
-
-
Co-author, "Supply Chain Issues in the Global Era," For the Defense, Think Globally column, July 2010, with Laura T. Vogel
-
Co-Author, Expert Witnesses: Products Liability Cases, 2009-2010 ed.
-
Author, "Think Globally - A New Column from the DRI International Law Committee," For the Defense, August 2009, with David Terry
-
Co-author, "Made in China: Five Opportunities Created by the Recent Recalls," For the Defense, International Law section, March 2009, with Kimberly K. Egan and Laura T. Vogel
-
Co-author, "The China Syndrome: Five Lessons to Learn from Recent Scandals Involving Chinese Products," Pharmaceutical Formulation & Quality, January 2009, with Kimberly K. Egan and Laura T. Vogel
-
Co-author, "A Next Step Toward the Middle Ground: The UK's Civil Justice Council's Latest Recommendations on Collective Action Reform in England and Wales," Across Frontiers, Fall 2008, with Leeanne S. Neri
-
Co-author, "US Class Actions: What Lessons Can Be Learned?" DRI Europe eNews, May 2008, with Skye Masson
-
Co-author, "Use of Experts in Product Liability and Mass Tort Litigation," Navigating the Labyrinth of Complex (Including Multidistrict) Product Liability Litigation, New York City Bar Association, March 2005, with Loren H. Brown and Rachel S. Geschwind
-
Co-author, "Motions In Limine in New York Products Liability Litigation," Products Liability in New York: Strategy and Practice, 2002 Supplement, Chapter 15 (Neil A. Goldberg ed., 2002), with Howard S. Hershenhorn and Loren H. Brown
-
Co-author, "The Alleged 'Overpromotion' of Prescription Drugs and Medical Devices – Is the Learned Intermediary Defense Still Alive?," DRI: Rx for the Defense, Fall 2001, with Loren H. Brown
-
Co-author, "Objections at Trial," Sweating the Small Stuff – The Basics on Motions, Objections, and Discovery, New York State Bar Association, October 2000, with Joseph G. Finnerty, Jr.
Seminars
-
Presenter, "Stop! Don't Eat That! Lessons from the Georgia Peanut Butter and Other Product Recalls," University of Georgia School of Law conference sponsored by the University of Georgia Business Law Society, Athens, Georgia (October 1, 2009)
-
Panelist, "Supply Chains in the Global Era: Prevention, Protection and Compliance," Association for Corporate Counsel Chicago Chapter luncheon, Chicago (July 22, 2009)
-
Presenter, "Motions Directed to the Pleadings," New York State Bar Association Continuing Legal Education program, New York City (May 19, 2009)
-
Speaker, "Good Cop Bad Cop: How to Conduct and Utilize Effective Background Investigations at Plaintiff Depositions," DRI Drug & Medical Device Web Conference (February 2009)
-
Speaker, "Motions to Dismiss: A Strategic Tool for Controlling the Pace and Venue of Multi-District Pharmaceutical Litigation," DRI Drug & Medical Device Seminar, New Orleans, Louisiana (May 2008)
-
Speaker, "Product Liability Litigation: A Comparison of United States and European Approaches and Growing Trends," Center for International Legal Studies, Salzburg, Austria (September 2004)
|
EDUCATION
Related Global Services
Related United States Services
Related Regions
Publications
View More
|
|